Tuesday, June 23, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 942 of 1,261
  1. US 8076357

    Compositions of n-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide

    Vertex Pharmaceuticals Incorporated · Granted Dec 13, 2011 · Expires Dec 8, 2031

    granted
  2. US 8076451

    Selective delivery of molecules into cells or marking of cells in diseased tissue regions using environmentally sensitive transmembrane peptide

    Board of Governors for Higher Education, State of Rhode Island and Providence Plantations · Granted Dec 13, 2011 · Expires Dec 8, 2031

    granted
  3. US 8076470

    VMP-like sequences of pathogenic Borrelia species and strains

    The Board of Regents of the University of Texas System · Granted Dec 13, 2011 · Expires Dec 8, 2031

    granted
  4. US 8076343

    Benzimidazoles useful as inhibitors of protein kinases

    Vertex Pharmaceuticals Incorporated · Granted Dec 13, 2011 · Expires Dec 8, 2031

    granted
  5. US 8076353

    Inhibition of VEGF translation

    PTC THERAPEUTICS, INC. · Granted Dec 13, 2011 · Expires Dec 8, 2031

    granted
  6. US 8076352

    Administration of carboline derivatives useful in the treatment of cancer and other diseases

    PTC THERAPEUTICS, INC. · Granted Dec 13, 2011 · Expires Dec 8, 2031

    granted
  7. US 8076412

    Water-soluble polymer alkanals

    Nektar Therapeutics · Granted Dec 13, 2011 · Expires Dec 8, 2031

    granted
  8. US 8076372

    Acythiols and component thiol compositions as anti-HIV and anti-retroviral agents

    The Government of the United States · Granted Dec 13, 2011 · Expires Dec 8, 2031

    granted
  9. AU 2010255748

    Stabilised composition comprising at least one adrenergic compound

    ALK AG [DK] · Granted Dec 8, 2011 · Expires Dec 3, 2031

    granted
  10. US 8071746

    Isolated nucleic acid molecule encoding a peptide or peptide analog comprising the SEQ ID No. 3

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Dec 6, 2011 · Expires Dec 1, 2031

    granted
  11. US 8071087

    Reovirus for the treatment of cellular proliferative disorders

    ONCOLYTICS BIOTECH INC. · Granted Dec 6, 2011 · Expires Dec 1, 2031

    granted
  12. US 8071323

    Human monoclonal antibodies that bind human insulin like growth factors and their use

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Dec 6, 2011 · Expires Dec 1, 2031

    granted
  13. US 8071618

    Caspase inhibitors and uses thereof

    Vertex Pharmaceuticals Incorporated · Granted Dec 6, 2011 · Expires Dec 1, 2031

    granted
  14. US 8071766

    HSP90 inhibitors

    Takeda Pharmaceutical Company Limited · Granted Dec 6, 2011 · Expires Dec 1, 2031

    granted
  15. US 8071807

    Antagonists of prostaglandin D2 receptors

    Panmira Pharmaceuticals, LLC · Granted Dec 6, 2011 · Expires Dec 1, 2031

    granted
  16. US 8071645

    Systems and methods for treating human inflammatory and proliferative diseases and wounds, with fatty acid metabolism inhibitors and/or glycolytic inhibitors

    The Regents of the University of Colorado · Granted Dec 6, 2011 · Expires Dec 1, 2031

    granted
  17. US 8071638

    Solid states of atorvastatin potassium

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Dec 6, 2011 · Expires Dec 1, 2031

    granted
  18. US 8071692

    Multi-arm block copolymers as drug delivery vehicles

    Nektar Therapeutics · Granted Dec 6, 2011 · Expires Dec 1, 2031

    granted
  19. US 8071678

    Thioester-terminated water soluble polymers and method of modifying the N-terminus of a polypeptide therewith

    Nektar Therapeutics · Granted Dec 6, 2011 · Expires Dec 1, 2031

    granted
  20. US 8071603

    Heterocyclic derivatives and their use as stearoyl-CoA desaturase inhibitors

    Xenon Pharmaceuticals Inc. · Granted Dec 6, 2011 · Expires Dec 1, 2031

    granted
  21. US 8071545

    Therapies and compositions for controlling the stress mechanism and for stabilizing hemostasis in an organism

    Lewis S. Coleman, MD, Inc. · Granted Dec 6, 2011 · Expires Dec 1, 2031

    granted
  22. US 8071564

    Regulation of angiogenesis with zinc finger proteins

    Sangamo Biosciences, Inc. · Granted Dec 6, 2011 · Expires Dec 1, 2031

    granted
  23. US 8071556

    Peptide substance revealing a stress protective effect, pharmaceutical composition on its base, and the method of its application

    Obschestvo S Ogranichennoi Otvetstvennostyu “Sia Peptides” · Granted Dec 6, 2011 · Expires Dec 1, 2031

    granted
  24. US 8071535

    Guanidinium derivatives for improved cellular transport

    The Regents of the University of California · Granted Dec 6, 2011 · Expires Dec 1, 2031

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.